DataLend: securities lending top 10 earning equities – March 9, 2015

DataLend presents its top 10 earnings equities for March 9, 2015. This list is built on DataLend¹s universe of more than 42,000 securities on loan.

Methodology: We scan our universe of more than 42,000 securities on loan to find those securities with the most expensive financing positions in the U.S., U.K., Europe and Asia. Financing costs are determined by taking the total on-loan value of a security and multiplying it by the volume-weighted average fees to borrow that security, then converting the product of those numbers to a dollar value. We then sort the most expensive securities to finance in the securities lending market in descending order.

US

Utilization

1     GAMESTOP CL A 89.89%
2     TRANSOCEAN 87.85%
3     ULTRA PETROLEUM 85.70%
4     AMBARELLA 94.98%
5     MANNKIND 95.97%
6     3D SYSTEMS 97.96%
7     NOW 98.40%
8     MYRIAD GENETICS 92.62%
9     INVENSENSE 81.16%
10   DIAMOND OFFSHORE DRILLING 82.61%

UK

Utilization

1     TALKTALK TELECOM GROUP 87.40%
2     ASOS 73.11%
3     ASHMORE GROUP 88.14%
4     QUINDELL 93.22%
5     LONMIN 92.71%
6     JSC VTB BANK GDR 24.75%
7     SAINSBURYJ 69.68%
8     BP 3.91%
9     STANDARD CHARTERED 18.55%
10   MONITISE 47.64%

Europe

Utilization

1     TRANSOCEAN (CH) 96.94%
2     GEMALTO (NL) 90.53%
3     GTECH (IT) 89.96%
4     SUEDZUCKER MANNHEIM OCHSENFURT (DE) 82.26%
5     TALKTALK TELECOM GROUP 87.40%
6     TOTAL (FR) 11.15%
7     GEMALTO (FR) 74.04%
8     AIR FRANCE-KLM (FR) 95.05%
9     TGS NOPEC GEOPHYSICAL (NO) 71.47%
10   MEYER BURGER TECHNOLOGY (CH) 95.05%

Far East/Australia Pacific

Utilization

1     HANERGY TFP (HK) 94.37%
2     CELLTRION (KR) 79.13%
3     EVERGRANDE (HK) 89.00%
4     DAUM KAKAO (KR) 80.01%
5     SANRIO (JP) 91.68%
6     GUNGHO ONLINE (JP) 81.78%
7     PRADA (HK) 76.69%
8     MIXI (JP) 77.71%
9     GREE (JP) 64.54%
10   CSR H (HK) 91.16%

This is just a snapshot of the rich data and functionalities provided by DataLend. Click here for more information about DataLend’s key features.


THE INFORMATION CONTAINED HEREIN IS PROPRIETARY TO EQUILEND; MAY NOT BE COPIED OR DISTRIBUTED WITHOUT THE EXPRESS CONSENT OF EQUILEND; SHALL NOT CONSTITUTE INVESTMENT ADVICE BY EQUILEND, OR ANY REPRESENTATIVE THEREOF; IS NOT WARRANTED TO BE ACCURATE, COMPLETE OR TIMELY; IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY; IS NOT INTENDED FOR TRADING PURPOSES; AND SHOULD NOT BE CONSTRUED AS EQUILEND MAKING FORECASTS, PROJECTING RETURNS OR RECOMMENDING ANY PARTICULAR COURSE OF ACTION. NEITHER EQUILEND NOR ANY REPRESENTATIVE THEREOF SHALL BE AN ADVISOR OR A FIDUCIARY OF A VISITOR TO THIS WEBSITE. EQUILEND IS NOT RESPONSIBLE OR LIABLE IN ANY WAY TO THE READER OR VISITOR, OR TO ANY PERSON, FIRM OR CORPORATION FOR ANY DAMAGES OR LOSSES ARISING FROM ANY USE OF THE INFORMATION CONTAINED HEREIN. IN CONSIDERING THE INFORMATION CONTAINED HEREIN, A VISITOR TO THIS WEBSITE DOES SO SOLELY IN RELIANCE ON THE VISITOR’S OWN JUDGMENT. PAST PERFORMANCE IS NO GUARANTEE OF FUTURE PERFORMANCE.

Related Posts

Fill out this field
Fill out this field
Please enter a valid email address.

Menu
X

Reset Password

Create an Account